Previously unrecognized class of antibodies can broadly neutralize multiple virus strains

Researchers have identified a previously unrecognized class of antibodies-;immune system proteins that protect against disease-;that appear capable of neutralizing multiple forms of flu virus.

Having celiac disease and a thyroid condition sent her on a quest to become an empathetic doctor

A third-year med school student, Brianna Celix doesn’t get a lot of free time. Even with the one afternoon off she gets each week at

August 18, 2023

‘Sweet spot’ of CNS cell therapy: Kenai emerges with $82M for Parkinson’s study

One of the first drugs that Jeff Jonas filed for approval was a Parkinson’s disease treatment. Now, a little over a quarter-century later, after executive

March 1, 2024

Patisiran Shows Long-Term Benefit in Hereditary ATTR With Polyneuropathy

Patisiran continued to demonstrate benefit in hATTR with polyneuropathy at 5 years. Measures of disability, polyneuropathy, and quality of life showed modest changes. This is

January 16, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.